Other substances

Psoralidin

A coumestan oestrogen receptor antagonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
5
 AI-suggested references
0
 Clinical trials

General information

Psoralidin on PubChem

Synonyms

3,9-Dihydroxy-2-prenylcoumestan

 

Structure image - Psoralidin

CC(=CCC1=CC2=C(C=C1O)OC(=O)C3=C2OC4=C3C=CC(=C4)O)C


 

Supporting references

Link Tested on Impact factor Notes Publication date
Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 Mpro
3CLpro Small molecule In silico 		in silico 3.27

Predicted to inhibit SARS-CoV-2 3C-like protease.

 Mar/11/2021

AI-suggested references

Link Publication date
Natural Products with tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 effects: A Drug Discovery Perspective against SARS-CoV-2.
Jul/28/2021
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
Apr/30/2020
Plant Products as Inhibitors of Coronavirus 3CL Protease.
Mar/09/2021
Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus
Oct/20/2020
Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach.
Apr/05/2021
Export (.csv)